|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 525.28 USD | +2.54% |
|
+0.01% | -7.88% |
| 03:18pm | UBS Adjusts Northrop Grumman Price Target to $685 From $666, Maintains Buy Rating | MT |
| 02:42pm | Karman Space & Defense Secures $21.3 Million US Navy Contract from Northrop Grumman | MT |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 10.76 | 9.18 | 3.66 | 7.13 | 6.64 | |||||
Return on Total Capital | 17.11 | 13.68 | 5.41 | 10.59 | 9.8 | |||||
Return On Equity % | 59.6 | 34.68 | 13.66 | 27.75 | 26.17 | |||||
Return on Common Equity | 59.6 | 34.68 | 13.66 | 27.75 | 26.17 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 20.38 | 20.42 | 16.67 | 20.38 | 19.81 | |||||
SG&A Margin | -0.64 | 3.1 | 9.94 | 7.05 | 7.07 | |||||
EBITDA Margin % | 24.49 | 20.98 | 10.14 | 16.67 | 16.26 | |||||
EBITA Margin % | 21.59 | 17.85 | 6.94 | 13.47 | 12.85 | |||||
EBIT Margin % | 21.01 | 17.32 | 6.73 | 13.33 | 12.75 | |||||
Income From Continuing Operations Margin % | 19.64 | 13.38 | 5.23 | 10.17 | 9.97 | |||||
Net Income Margin % | 19.64 | 13.38 | 5.23 | 10.17 | 9.97 | |||||
Net Avail. For Common Margin % | 19.64 | 13.38 | 5.23 | 10.17 | 9.97 | |||||
Normalized Net Income Margin | 12.29 | 9.97 | 3.58 | 7.64 | 7.14 | |||||
Levered Free Cash Flow Margin | 18.11 | 9.87 | 4.16 | 9.89 | 6.91 | |||||
Unlevered Free Cash Flow Margin | 19.09 | 10.73 | 5.02 | 10.84 | 7.9 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.82 | 0.85 | 0.87 | 0.86 | 0.83 | |||||
Fixed Assets Turnover | 3.93 | 3.63 | 3.56 | 3.45 | 3.34 | |||||
Receivables Turnover (Average Receivables) | 5.25 | 5.06 | 5.37 | 5.73 | 5.56 | |||||
Inventory Turnover (Average Inventory) | 36.18 | 32.56 | 31.37 | 25.48 | 24.34 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.3 | 1.08 | 1.15 | 1.01 | 1.1 | |||||
Quick Ratio | 1.16 | 0.94 | 0.98 | 0.85 | 0.95 | |||||
Operating Cash Flow to Current Liabilities | 0.37 | 0.25 | 0.32 | 0.31 | 0.34 | |||||
Days Sales Outstanding (Average Receivables) | 69.59 | 72.06 | 68.01 | 63.9 | 65.68 | |||||
Days Outstanding Inventory (Average Inventory) | 10.09 | 11.21 | 11.63 | 14.36 | 14.99 | |||||
Average Days Payable Outstanding | 25.68 | 29.8 | 26.08 | 26.1 | 31.81 | |||||
Cash Conversion Cycle (Average Days) | 54 | 53.47 | 53.56 | 52.16 | 48.86 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 113.39 | 97.96 | 108.47 | 120.31 | 107.26 | |||||
Total Debt / Total Capital | 53.14 | 49.49 | 52.03 | 54.61 | 51.75 | |||||
LT Debt/Equity | 111.15 | 89.01 | 105.97 | 107.85 | 102.07 | |||||
Long-Term Debt / Total Capital | 52.09 | 44.96 | 50.83 | 48.95 | 49.25 | |||||
Total Liabilities / Total Assets | 69.64 | 65.01 | 68.21 | 69.02 | 67.55 | |||||
EBIT / Interest Expense | 13.48 | 12.53 | 4.85 | 8.81 | 8.04 | |||||
EBITDA / Interest Expense | 16.47 | 16 | 8.18 | 11.77 | 11.03 | |||||
(EBITDA - Capex) / Interest Expense | 13.93 | 13.17 | 4.92 | 8.92 | 8.85 | |||||
Total Debt / EBITDA | 1.6 | 1.85 | 3.6 | 2.52 | 2.44 | |||||
Net Debt / EBITDA | 1.17 | 1.49 | 2.83 | 1.87 | 1.77 | |||||
Total Debt / (EBITDA - Capex) | 1.89 | 2.25 | 5.98 | 3.32 | 3.04 | |||||
Net Debt / (EBITDA - Capex) | 1.38 | 1.81 | 4.7 | 2.47 | 2.21 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -3.08 | 2.62 | 7.34 | 4.44 | 2.24 | |||||
Gross Profit, 1 Yr. Growth % | -2.81 | 2.83 | -12.35 | 27.64 | -0.59 | |||||
EBITDA, 1 Yr. Growth % | 58.92 | -12.07 | -48.14 | 71.7 | -0.28 | |||||
EBITA, 1 Yr. Growth % | 71.43 | -15.12 | -58.3 | 102.79 | -2.41 | |||||
EBIT, 1 Yr. Growth % | 77.23 | -15.44 | -58.27 | 106.77 | -2.21 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 119.66 | -30.11 | -58.01 | 103.02 | 0.19 | |||||
Net Income, 1 Yr. Growth % | 119.66 | -30.11 | -58.01 | 103.02 | 0.19 | |||||
Normalized Net Income, 1 Yr. Growth % | 88.09 | -16.77 | -61.46 | 123.03 | -4.47 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 128.8 | -27.72 | -57.01 | 109.46 | 2.61 | |||||
Accounts Receivable, 1 Yr. Growth % | 4.79 | 7.69 | -4.63 | 0.46 | 10.29 | |||||
Inventory, 1 Yr. Growth % | 6.85 | 20.59 | 13.39 | 31.2 | -10.03 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 10.98 | 11.12 | 8.1 | 7.28 | 4.27 | |||||
Total Assets, 1 Yr. Growth % | -4.25 | 2.76 | 6.37 | 6.05 | 4.09 | |||||
Tangible Book Value, 1 Yr. Growth % | -33.09 | -49.91 | 16.96 | -18.2 | -60.78 | |||||
Common Equity, 1 Yr. Growth % | 22.19 | 18.46 | -3.38 | 3.35 | 9.05 | |||||
Cash From Operations, 1 Yr. Growth % | -17.14 | -18.67 | 33.57 | 13.24 | 8.41 | |||||
Capital Expenditures, 1 Yr. Growth % | -0.35 | 1.41 | 23.69 | -0.45 | -17.94 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 793 | -44.09 | -54.8 | 148.7 | -28.57 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 522.27 | -42.3 | -49.77 | 125.44 | -25.46 | |||||
Dividend Per Share, 1 Yr. Growth % | 8.64 | 9.74 | 8.58 | 9.67 | 11.68 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 2.66 | -0.27 | 4.96 | 5.88 | 3.33 | |||||
Gross Profit, 2 Yr. CAGR % | 0.06 | -0.03 | -5.06 | 5.77 | 12.65 | |||||
EBITDA, 2 Yr. CAGR % | 43.63 | 18.21 | -32.47 | -5.63 | 30.85 | |||||
EBITA, 2 Yr. CAGR % | 52.72 | 20.63 | -40.51 | -8.04 | 40.68 | |||||
EBIT, 2 Yr. CAGR % | 58.88 | 22.42 | -40.59 | -7.11 | 42.19 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 76.52 | 23.91 | -45.82 | -7.67 | 42.62 | |||||
Net Income, 2 Yr. CAGR % | 76.52 | 23.91 | -45.82 | -7.67 | 42.62 | |||||
Normalized Net Income, 2 Yr. CAGR % | 65.89 | 25.12 | -43.37 | -7.29 | 45.97 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 81.48 | 28.6 | -44.26 | -5.1 | 46.6 | |||||
Accounts Receivable, 2 Yr. CAGR % | 2.22 | 6.23 | 1.34 | -2.12 | 5.26 | |||||
Inventory, 2 Yr. CAGR % | 1.77 | 13.51 | 16.94 | 21.97 | 8.64 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 6.47 | 11.05 | 9.6 | 7.69 | 5.76 | |||||
Total Assets, 2 Yr. CAGR % | 1.8 | -0.81 | 4.55 | 6.21 | 5.06 | |||||
Tangible Book Value, 2 Yr. CAGR % | -31.24 | -42.11 | -23.46 | -2.19 | -43.36 | |||||
Common Equity, 2 Yr. CAGR % | 21.07 | 20.31 | 6.99 | -0.07 | 6.16 | |||||
Cash From Operations, 2 Yr. CAGR % | -8.89 | -17.91 | 4.23 | 22.99 | 10.8 | |||||
Capital Expenditures, 2 Yr. CAGR % | 5.8 | 0.53 | 12 | 10.97 | -9.62 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 88.43 | 123.44 | -49.73 | 6.02 | 33.28 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 77.97 | 89.48 | -46.17 | 6.41 | 29.63 | |||||
Dividend Per Share, 2 Yr. CAGR % | 9.26 | 9.19 | 9.16 | 9.13 | 10.67 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 5.83 | 2.65 | 2.21 | 4.78 | 4.65 | |||||
Gross Profit, 3 Yr. CAGR % | 2.14 | 0.98 | -4.32 | 4.78 | 3.61 | |||||
EBITDA, 3 Yr. CAGR % | 20.41 | 21.96 | -10.18 | -7.83 | -3.88 | |||||
EBITA, 3 Yr. CAGR % | 20.45 | 25.56 | -15.34 | -10.47 | -6.2 | |||||
EBIT, 3 Yr. CAGR % | 21.27 | 28.76 | -14.48 | -9.97 | -5.5 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 29.45 | 29.62 | -13.61 | -15.85 | -5.12 | |||||
Net Income, 3 Yr. CAGR % | 29.45 | 29.62 | -13.61 | -15.85 | -5.12 | |||||
Normalized Net Income, 3 Yr. CAGR % | 22.97 | 31.82 | -15.5 | -10.57 | -6.36 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 33.04 | 33.52 | -10.75 | -13.34 | -2.6 | |||||
Accounts Receivable, 3 Yr. CAGR % | 2.44 | 4.01 | 2.48 | 1.05 | 1.86 | |||||
Inventory, 3 Yr. CAGR % | 7.44 | 7.69 | 13.47 | 21.51 | 10.2 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 14.44 | 8 | 10.06 | 8.82 | 6.54 | |||||
Total Assets, 3 Yr. CAGR % | 4.18 | 2.12 | 1.53 | 5.05 | 5.5 | |||||
Tangible Book Value, 3 Yr. CAGR % | -24.19 | -38.13 | -26.81 | -21.75 | -27.88 | |||||
Common Equity, 3 Yr. CAGR % | 16.44 | 20.19 | 11.83 | 5.76 | 2.88 | |||||
Cash From Operations, 3 Yr. CAGR % | -2.32 | -12.27 | -3.45 | 7.15 | 17.92 | |||||
Capital Expenditures, 3 Yr. CAGR % | 4.25 | 4.32 | 7.72 | 7.69 | 0.35 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 133.48 | 25.68 | 31.16 | -14.35 | -7.06 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 99.39 | 22.26 | 21.72 | -13.23 | -5.5 | |||||
Dividend Per Share, 3 Yr. CAGR % | 9.44 | 9.42 | 8.99 | 9.33 | 9.97 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 7.62 | 7.08 | 5.48 | 3.93 | 2.66 | |||||
Gross Profit, 5 Yr. CAGR % | 4.23 | 4.74 | -0.8 | 2.87 | 2.14 | |||||
EBITDA, 5 Yr. CAGR % | 20.81 | 9.28 | -4.46 | 10.06 | 4.41 | |||||
EBITA, 5 Yr. CAGR % | 21.12 | 7.91 | -9.16 | 10.85 | 3.73 | |||||
EBIT, 5 Yr. CAGR % | 20.6 | 7.31 | -8.85 | 13 | 4.81 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 27.95 | 11.28 | -8.63 | 13.18 | 5.57 | |||||
Net Income, 5 Yr. CAGR % | 27.95 | 11.28 | -8.63 | 13.18 | 5.57 | |||||
Normalized Net Income, 5 Yr. CAGR % | 21.2 | 6.65 | -9.82 | 14.51 | 5.15 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 30.92 | 14.01 | -6.06 | 16.48 | 8.85 | |||||
Accounts Receivable, 5 Yr. CAGR % | 16.1 | 10.65 | 2 | 1.52 | 3.58 | |||||
Inventory, 5 Yr. CAGR % | -0.12 | 19.7 | 11.14 | 13.19 | 11.52 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 21.62 | 20.22 | 12.48 | 7.88 | 8.32 | |||||
Total Assets, 5 Yr. CAGR % | 10.7 | 4.49 | 4.33 | 3.74 | 2.93 | |||||
Tangible Book Value, 5 Yr. CAGR % | -6.56 | -13.6 | -23.9 | -25.69 | -33.95 | |||||
Common Equity, 5 Yr. CAGR % | 19.7 | 16.51 | 12.56 | 11.63 | 9.53 | |||||
Cash From Operations, 5 Yr. CAGR % | 4.86 | 2.11 | 0.25 | 0.42 | 2.02 | |||||
Capital Expenditures, 5 Yr. CAGR % | 8.99 | 9.11 | 7.28 | 6.93 | 0.42 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 38.93 | 15.48 | 26.32 | 17.41 | 32 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 36.51 | 14.64 | 18.1 | 15.65 | 24.82 | |||||
Dividend Per Share, 5 Yr. CAGR % | 11.97 | 11.63 | 9.32 | 9.3 | 9.66 |
- Stock Market
- Stocks
- NOC Stock
- Financials Northrop Grumman Corporation
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















